Riskpilot← Back to searchSign inGet full accessNHPEA Tissue Holdings AB
ABActiveOrg 5569120198Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 20120 employees
Revenue 2024
SEK 0
EBITDA margin
—
+88% vs 2023
Equity ratio
95.7%
Financial strength
Net profit 2024
SEK 1,2B
+21948% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -756K | +88% |
| Net profit | SEK 1,2B | +21948% |
| Total assets | SEK 1,3B | +100% |
| Equity | SEK 1,2B | +91% |
| Employees | 0 | — |
Legal name
NHPEA Tissue Holdings AB
Org number
5569120198
Legal form
Aktiebolag
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
28 november 2012
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna
Company purpose
Bolaget skall bedriva holdingbolagsverksamhet innebärande ägande och förvaltande av värdepapper samt förvalta fast och lös egendom och bedriva därmed förenlig verksamhet.
Address
Email
stephan.dejonge@nhpinvestments.nl
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −1 279 | −13 436 | −8 544 | −6 081 | −756 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −1 279 | −13 436 | −8 544 | −6 081 | −756 |
| Net financials | 248 337 | 1 014 | 629 | 391 | 1 403 867 |
| Profit before tax | 248 501 | −12 422 | −7 914 | −5 691 | 1 403 111 |
| Tax | −0 | −0 | −0 | −0 | −159 717 |
| Net profit | 248 501 | −12 422 | −7 914 | −5 691 | 1 243 394 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 666 398 | 654 806 | 654 610 | 651 105 | 1 299 447 |
| Equity | 665 959 | 653 988 | 646 583 | 650 356 | 1 244 079 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 439 | 818 | 8 027 | 749 | 55 368 |
| Total debt | 439 | 818 | 8 027 | 749 | 55 368 |
EBITDA margin
-75600000.0%
This company
15.8%
Market median
-478481113% vs market
20202024
Equity ratio
95.7%
This company
38.2%
Market median
+151% vs market
20202024
Return on equity
99.9%
This company
18.4%
Market median
+443% vs market
20202024
Net profit margin
124339400000.0%
This company
8.1%
Market median
+1535054320888% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AR Chief Auditor | Chief Auditor | 2021 |
SC Authorized Recipient of Service | Authorized Recipient of Service | 2024 |
| Former (6) | ||
EA Authorized Recipient of Service | Authorized Recipient of Service | 2020 – 2021 |
LP Authorized Recipient of Service | Authorized Recipient of Service | 2021 – 2022 |
NJ Authorized Recipient of Service | Authorized Recipient of Service | 2022 – 2024 |
CB Authorized Recipient of Service | Authorized Recipient of Service | 2022 – 2023 |
PM Chief Auditor | Chief Auditor | 2022 – 2023 |
SD Chief Auditor | Chief Auditor | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Former (5) | ||
| Chairman | 2020 – 2022 | |
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2023 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NHPEA Tissue Holdings AB (this company)
Mss Holdings Co,. LtdBoard members of NHPEA Tissue Holdings AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Emma Alexandra Wessman | Authorized Recipient of Service | 0 companies |
| Anna Rozhdestvenskaya | Chief Auditor | 0 companies |
| Lars Pontus Söderlind | Authorized Recipient of Service | 0 companies |
| Sara Charlotta Margareta Möller | Authorized Recipient of Service | 0 companies |
| Nathalie Jessica Grip | Authorized Recipient of Service | 0 companies |
| Carl-Axel Benjamin Åfors | Authorized Recipient of Service | 0 companies |
| Peter Mikael Ikonen | Chief Auditor | 0 companies |
| Stig Daniel Öberg | Chief Auditor | 0 companies |
| Stephan Jacobus Marceau de Jonge | Chairman | 0 companies |
| Simon Luke Walker | Board of Directors | 0 companies |
| Tessa Elize Hart | Board of Directors | 0 companies |
| Cathelijne Charlotte Kok | Board of Directors | 0 companies |
| Arno Kikkert | Board of Directors | 0 companies |
| Abdelilah Nahari | Chairman | 0 companies |
| Marieke Louman | Board of Directors | 0 companies |
| Mathias Ruben Meijer | Board of Directors | 0 companies |